tazemetostat

Epizyme's Cancer Drug to Get Rapid FDA Review for a New Indication
Motley Fool
Fri, 02/14/20 - 04:58 pm
Epizyme
FDA
tazemetostat
follicular lymphoma
Migraine, cholesterol upstarts top the list of FDA decisions to watch this quarter
Fierce Pharma
Fri, 01/3/20 - 11:03 pm
FDA
migraines
cholesterol
Epizyme
tazemetostat
Esperion
bempedoic acid
teprotumumab
Horizon Therapeutics
Biohaven
rimegepant
FDA’s in-house review offers bleak assessment of Epizyme’s tazemetostat — but win or lose this cancer drug may still have a future
Endpoints
Tue, 12/17/19 - 10:27 am
Epizyme
FDA
tazemetostat
epithelioid sarcoma
The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week
Yahoo/Benzinga
Sun, 12/15/19 - 11:28 pm
Epizyme
tazemetostat
Avadel
AV001
FDA
Epizyme announces FDA filing acceptance of new drug application and priority review for tazemetostat to treat epithelioid sarcoma
Pharmaceutical Business Review
Fri, 07/26/19 - 11:02 am
Epizyme
FDA
tazemetostat
epithelioid sarcoma
ASCO: With FDA review nearing, Epizyme shares updated sarcoma data
Fierce Biotech
Mon, 06/3/19 - 11:32 am
ASCO 2019
Epizyme
clinical trials
tazemetostat
epithelioid sarcoma
Epizyme moves forward with cancer drug, eyes 2020 launch
Biopharma Dive
Thu, 05/30/19 - 05:37 pm
Epizyme
FDA
tazemetostat
epithelioid sarcoma
FDA gives Epizyme a green light on trial recruitment, but tazemetostat isn’t completely out of the woods yet
Endpoints
Mon, 09/24/18 - 09:45 am
Epizyme
clinical trials
FDA
tazemetostat
Despite FDA hold, Epizyme’s tazemetostat posts positive interim data
Fierce Biotech
Fri, 06/15/18 - 09:53 pm
Epizyme
tazemetostat
follicular lymphoma
FDA
FDA Pumps the Brakes on Epizyme’s Top Cancer Drug Tazemetostat
Xconomy
Mon, 04/23/18 - 10:44 pm
clinical trials
FDA
Epizyme
tazemetostat
Epizyme partners with Roche to test cancer drug combo
BioPharma Dive
Thu, 06/23/16 - 08:22 pm
Epizyme
Roche
PDL-1 inhibitors
diffuse large B-cell lymphoma
Tecentriq
tazemetostat
Epizyme’s Cancer Drug Studies to Continue; Some Tumors Wiped Out
Bloomberg
Mon, 06/20/16 - 09:53 am
Epizyme
cancer
tazemetostat
non-Hodgkin's lymphoma
Epizyme lays out plans to have its cancer drug approved as soon as 2018
Bizjournals.com
Thu, 03/10/16 - 10:51 am
Epizyme
tazemetostat
solid tumors
non-Hodgkin's lymphoma
Epizyme Beats Out the Market With FDA Approval
Yahoo/24-7 Wall St
Mon, 08/24/15 - 05:00 pm
FDA
Epizyme
tazemetostat
INI1-negative tumors
synovial sarcoma